16639-86-4 Usage
General Description
L-Alanine, N-(ethoxycarbonyl)- is a compound used in organic synthesis and chemical reactions. It is a derivative of the amino acid L-alanine, where the carboxyl group has been protected with an ethoxycarbonyl group. This protection group is commonly used to prevent unwanted interactions during chemical reactions, and can be removed later to reveal the original functionality of the molecule. L-Alanine, N-(ethoxycarbonyl)- is often used in peptide synthesis, as well as in the production of pharmaceuticals and other organic compounds. It has a variety of applications in research and industry, and is an important building block for the creation of complex organic molecules.
Check Digit Verification of cas no
The CAS Registry Mumber 16639-86-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,6,6,3 and 9 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 16639-86:
(7*1)+(6*6)+(5*6)+(4*3)+(3*9)+(2*8)+(1*6)=134
134 % 10 = 4
So 16639-86-4 is a valid CAS Registry Number.
16639-86-4Relevant articles and documents
A Straightforward and High-Yielding Synthesis of 1,2,4-Oxadiazoles from Chiral N-Protected α-Amino Acids and Amidoximes in Acetone-Water: An Eco-Friendly Approach
Sauer, André C.,Wolf, Lucas,Quoos, Natália,Rodrigues, Mariele B.,Braga, Ant?nio L.,Rodrigues, Oscar E. D.,Dornelles, Luciano
, (2019)
A straightforward and high-yielding methodology for the synthesis of a high structural diversity of 1,2,4-oxadiazoles from different chiral N-protected α-amino acids and amidoximes under microwave (MW) irradiation is described herein. This greener approac
HEPATITIS C VIRUS INHIBITORS
-
Page/Page column 69, (2012/02/15)
The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
HEPATITIS C VIRUS INHIBITORS
-
Page/Page column 69, 71, (2011/06/16)
The present disclosure relates to methods for making compounds useful in the treatment of Hepatitis C virus (HCV) infection.